Biotech joins life science collective at Canary Wharf

UK biotech company Myricx Bio, focused on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs) for the treatment of cancer, has been welcomed by Kadans Science Partner to its London Innovation Centre at Canary Wharf.

Taking a mix of laboratory and office space, the biotech joins other life sciences companies based  at the centre, which comprises 40,000 sq. ft of fully fitted, flexible, CL2 wet labs and offices, ranging from bespoke 250 sq. ft to over 2,000 sq. ft labs, with tenants having the option of renting a bench in the CoWorking lab, or taking their own private lab. 

Following its recent £90m ($114m) Series A financing, Myricx is building out its proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform as well as advancing its pipeline of NMTi-ADCs through clinical proof of concept, targeting clinically validated tumour-associated antigens. The company was spun out of Imperial College London and the Francis Crick Institute in 2019.

Myricx Bio COO, Julie Mead commented: “We are excited to take this next step and join Kadans’ London Innovation Centre as we grow our in-house R&D capabilities and management team, following the recent close of our £90m Series A financing.

“When looking to expand our footprint, it was important to us that we located a supportive, well-connected and dynamic environment in London, where we were founded, especially as we prepare to become a clinical stage company. We have found that environment in the Canary Wharf ecosystem, where the London Innovation Centre offers us excellent lab and office facilities, as well as a wider biotech network, which together will  support our next phase of growth.”

Katie Nelson, Head of Leasing UK & Ireland, Kadans Science Partner, said: “We are really pleased that Myricx has chosen the London Innovation Centre to establish its headquarters, joining the growing community of life sciences companies at the facility and across the Canary Wharf estate. Kadans Science Partner ethos is to support our tenants with the full life cycle of their journey through its connected ecosystem which we can do across our London, UK and European Portfolio. 

More information online